XML 49 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense
   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
(in thousands)  2021   2020   2021   2020 
Research and development  $858   $134   $3,861   $364 
General and administrative   1,567    75    6,084    190 
Total stock-based compensation  $2,425   $209   $9,945   $554 

 

Schedule of outstanding common stock options and related activity
Equity  Number of Options   Weighted
Average
Exercise
Price
Per Share
   Weighted
Average
Remaining
Term
(Years)
   Intrinsic
Value
 
Outstanding - December 31, 2020   7,032,591   $0.97    5.34   $62,462 
Granted   2,574,441    8.85    9.61    
-
 
Exercised   (409,867)   1.04    
-
    2,373 
Forfeited   (133,742)   8.66    
-
    
-
 
Outstanding - September 30, 2021   9,063,423   $3.09    5.90   $38,863 
Options vested and exercisable - September 30, 2021   6,000,723   $0.82    4.33   $36,247 
Stock options vested and expected to vest - September 30, 2021   9,063,423   $3.09    5.90   $38,863 

  

Schedule of assumptions used to calculate the fair value of stock options
   Nine months ended
September 30,
2021
 
Expected stock price volatility   84.8 – 87.4%
Risk-free interest rate   0.59 – 0.94%
Expected dividend yield   0.00%
Expected term   6.00 years   

 

Schedule of restricted common stock activity
   Number of
Restricted Stock Awards
   Weighted-
Average
Grant
Date Fair
Value
 
Outstanding and unvested balance as of December 31, 2020   1,507,062   $10.30 
Converted to shares of Common Stock upon vesting   (224,109)   
-
 
Forfeited   (37,464)   10.82 
Outstanding and unvested balance as of September 30, 2021   1,245,489   $10.14